42.20 USD
▲-0.19+3.46%
盘后 40.79 0.00%
2026-08-03
市值
$2.02B
市盈率
—
EPS
-2.56
股息率
—
52 周区间
13.62 – 44.28
成交量
398.03K
Beta
0.95
目标价
58.59
52W 低 13.6252W 高 44.28
价格走势
公司简介
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company’s lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorde...